Related Experiment Video
Updated: Jun 3, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
miR-34 as a Critical Regulator in Ovarian Cancer
Mahrokh Abouali Gale Dari1, Bahar Jaberian Asl2, Dian Dayer3
1Department of Obstetrics and Gynecology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract:
Ovarian cancer (OC) is a gynecologic disease characterized by the uncontrolled growth and proliferation of abnormal cells in the ovaries, fallopian tubes, or peritoneum. Emerging evidence has shown the pivotal role of non-coding RNAs (ncRNAs), such as miRNAs, in driving the pathogenesis of OC. miRNAs are recognized as small ncRNAs that play critical roles in regulating gene expression in normal development and in disease states, including OC. Among miRNAs, the expression of miR-34a was found to be downregulated in OC. Elevated levels of this miRNA are associated with the induction of apoptosis and the inhibition of OC cell proliferation by targeting various signaling pathways, including NOTCH1, P21/P53, STAT3, and BCL2 in OC. Therefore, miR-34a can be a therapeutic target in the management of OC. In this review, we summarized the functional significance of this miRNA in the treatment of OC.
Insights
MicroRNAs (miRNAs) are key in ovarian cancer (OC) development. Specifically, miR-34a downregulation in OC suggests its potential as a therapeutic target to inhibit cancer cell growth and induce apoptosis.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- RNA Therapeutics
Background:
- Ovarian cancer (OC) is a significant gynecologic malignancy driven by uncontrolled cell proliferation.
- Non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), are increasingly recognized for their crucial roles in OC pathogenesis.
- Downregulation of miR-34a has been observed in OC tissues, indicating its potential tumor-suppressive function.
Purpose of the Study:
- To review the functional significance of miR-34a in ovarian cancer.
- To explore the therapeutic potential of targeting miR-34a for OC management.
Main Methods:
- Literature review summarizing existing research on miR-34a in ovarian cancer.
- Analysis of miR-34a's regulatory roles in key signaling pathways implicated in OC.
- Evaluation of miR-34a's impact on apoptosis and cell proliferation in OC models.
Main Results:
- miR-34a acts as a tumor suppressor in OC by targeting critical signaling pathways like NOTCH1, P21/P53, STAT3, and BCL2.
- Restoration of miR-34a levels can induce apoptosis and inhibit OC cell proliferation.
- The observed downregulation of miR-34a correlates with OC progression.
Conclusions:
- miR-34a holds significant promise as a therapeutic target for ovarian cancer.
- Modulating miR-34a expression could represent a novel strategy for OC treatment.
- Further research into miR-34a-based therapies is warranted for clinical application.
